BeiGene, Ltd. (BGNE)
Last Price$226.70.0%
Market Cap$1,846.9M
LTM EPS
($7.68)
EPS growth
(35.6%)
Ben Graham Fair Value
$413.2
Undervalued (Ben Graham formula)
82.3%
Stock quality
5/10
Good
BGNE Ben Graham Fair Value
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
BGNE EPS growth & Dividend Yield
Crunching data... Almost there!
BGNE vs Peer Set: Ben Graham Fair Value Comparison
Crunching data... Almost there!
Explore more intrinsic value tools hub for BGNE
Peter Lynch Fair Value
Reverse DCF
Earnings growth model
Earnings Power Value
Discount rate
Relative Value
Intrinsic Value
Margin of safety
DCF value calculator
Peter Lynch charts
FAQ
What is BeiGene, Ltd.'s fair value according to the Ben Graham formula?
As of Sep 30, 2024, BeiGene, Ltd.'s fair value using the Ben Graham formula is $413.2 per share. This is calculated using Ben Graham formula, where EPS is ($7.7) and BVPS (Book Value Per Share) is $32.8. The current price of $226.7 suggests BeiGene, Ltd. may be overvalued by this conservative metric.
What is BeiGene, Ltd. earnings per share (EPS)?
BeiGene, Ltd. earnings per share (EPS) for the twelve months ending Sep 30, 2024, was ($7.7), a (35.6%) growth year-over-year.
What is BeiGene, Ltd.'s margin of safety based on the Ben Graham analysis?
BeiGene, Ltd.'s margin of safety is positive 82.3%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.